Point72 Hong Kong LTD Agenus Inc Transaction History

Point72 Hong Kong LTD

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$1.96 - $3.14 $158,366 - $253,708	80,799 New	80,799 $166,000
Q2 2022 Aug 15, 2022	SELL	$1.3 - $2.64 $48,113 - $97,706	-37,010 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.35 - $3.47 $86,973 - $128,424	37,010 New	37,010 $91,000
Q4 2021 Feb 14, 2022	SELL	$2.92 - $5.74 $97,507 - $191,675	-33,393 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$4.98 - $6.63 $166,297 - $221,395	33,393 New	33,393 $175,000
Q2 2021 Aug 16, 2021	SELL	$2.56 - $5.49 $22,932 - $49,179	-8,958 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$2.69 - $5.25 $15,965 - $31,158	5,935 Added 196.33%	8,958 $24,000
Q4 2020 Feb 16, 2021	BUY	$3.17 - $4.49 $9,582 - $13,573	3,023 New	3,023 $10,000
Q2 2020 Aug 14, 2020	SELL	$2.29 - $4.24 $1,232 - $2,281	-538 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$1.92 - $4.39 $1,032 - $2,361	538 New	538 $1,000
Q3 2018 Nov 14, 2018	SELL	$1.59 - $2.42 $11,513 - $17,523	-7,241 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$2.26 - $4.65 $16,364 - $33,670	7,241 New	7,241 $16,000

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.